Outcomes of bleeding peptic ulcers: A prospective study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 8 PART2, 2008, Pages

  Liu, Nai Jen ^a   Lee, Ching Song ^a   Tang, Jui Hsiang ^a   Cheng, Hao Tsai ^a   Chu, Yin Yi ^a   Sung, Kai Feng ^a   Lin, Cheng Hui ^a   Tsou, Yung Kuan ^a   Lien, Jau Min ^a   Chen, Pang Chi ^a   Chiu, Cheng Tang ^a   Cheng, Chi Liang ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Helicobacter pylori; Non steroidal anti inflammatory drugs; Outcome; Ulcer bleeding

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; NONSTEROID ANTIINFLAMMATORY AGENT; TICLOPIDINE; UREASE;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL EVALUATION; COMORBIDITY; DEATH; DIAGNOSTIC TEST; DRUG USE; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; OUTCOME ASSESSMENT; OUTPATIENT; PEPTIC ULCER BLEEDING; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; STATISTICAL SIGNIFICANCE;

EID: 48549101075     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05179.x     Document Type: Article

References (27)

1. Gisbert JP, Gonzalez L, de Pedro A et al. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Scand. J. Gastroenterol. 2001 36 : 717 24.
2. Schilling D, Demel A, Nusse T, Weidmann E, Reimann JF. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial. Endoscopy 2003 35 : 393 6.
3. Okan A, Tankurt E, Aslan BU, Akpinar H, Simsek I, Gonen O. Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcer: a case-control study. J. Gastroenterol. Hepatol. 2003 18 : 18 25.
4. Ramsoekh D, van Leerdam ME, Rauws EAJ, Tytgat GNJ. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection. Clin. Gastroenterol. Hepatol. 2005 3 : 859 64.
5. Wilcox CM, Allison J, Benzuly K et al. Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 inhibitors and aspirin. Clin. Gastroenterol. Hepatol. 2006 4 : 1082 9.
6. Chan HLY, Wu JCW, Chan FKL et al. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients. Gastrointest. Endosc. 2001 53 : 438 42.
7. Hung LCT, Ching JYL, Sung JJY et al. Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology 2005 128 : 1845 50.
8. Adamopoulos AB, Efstathiou SP, Tsioulos DI et al. Bleeding duodenal ulcer: comparison between Helicobacter pylori positive and Helicobacter pylori negative bleeders. Dig. Liver. Dis. 2004 36 : 13 20.
9. Rockall TA, Logan FRA, Devlin HB, Northfield TC. for the steering committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996 38 : 316 21.
10. Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 1974 2 (7877 394 7.
11. Barkun A, Sabbah S, Enns R et al. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am. J. Gastroenterol. 2004 99 : 1238 46.
12. Barkun A, Bardou M, Marshall JK for the Nonvariceal Upper GI Bleeding Consensus Conference Group. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann. Intern. Med. 2003 139 : 843 57.
13. Lin HJ, Lo WC, Lee FY, Perng CL, Tseng GY. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch. Intern. Med. 1998 158 : 54 8.
14. Lau JYW, Sung JJY, Lee KKC et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N. Engl. J. Med. 2000 343 : 310 16.
15. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis: enhanced efficacy of proton-pump inhibitor therapy for peptic ulcer bleeding in Asia - a post hoc analysis from the Cochrane Collaboration. Aliment. Pharmacol. Ther. 2005 21 : 1055 61.
16. Lanas A, Sekar MC, Hirschowitz BI. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992 103 : 862 9.
17. Lanas A, Serrano P, Bajador E, Esteva F, Benito R, Sainz R. Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology 1997 112 : 683 9.
18. Lee JM, Breslin NP, Fallon C, O'Morain CA. Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding. Am. J. Gastroenterol. 2000 95 : 1166 70.
19. Houghton J, Ramamoorthy R, Pandya H, Dhirmalani R, Kim KH. Human plasma is directly bactericidal against Helicobacter pylori in vitro, potentially explaining the decreased detection of Helicobacter pylori during acute upper GI bleeding. Gastrointest. Endosc. 2002 55 : 11 16.
20. Laine L, Sidhom O, Emami S, Estrada R, Cohen H. Effect of blood on rapid urease testing of gastric mucosal biopsy specimens. Gastrointest. Endosc. 1998 47 : 141 3.
21. Jyotheeswaran S, Shah AN, Jin HO et al. Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified? Am. J. Gastroenterol. 1998 93 : 574 8.
22. Harris AW, Gummett PA, Phull PS, Jacyna MR, Misiewicz JJ, Baron JH. Recurrence of duodenal ulcer after Helicobacter pylori eradication is related to high acid output. Aliment. Pharmacol. Ther. 1997 11 : 331 4.
23. Gillen D, Wirz AA, Neithercut WD, Ardill JES, McColl KEL. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut 1999 44 : 468 75.
24. Lopez-Brea M, Alarcon T, Megraud F. Diagnosis of Helicobacter pylori infection. Curr. Opin. Gastroen. 1997 13 (Suppl. 1 13 19.
25. Cohen H, Laine L. Endoscopic methods for the diagnosis of Helicobacter pylori. Aliment. Pharmacol. Ther. 1997 11 (Suppl. 1 3 9.
26. Laine L, Lewin DN, Naritoku W, Cohen H. Prospective comparison of H & E, Giemsa, and Genta stains for the diagnosis of Helicobacter pylori. Gastrointest. Endosc. 1997 45 : 463 7.
27. Udd M, Miettinen P, Palmu A, Julkunen R. Effects of short-term treatment with regular or high dose of omeprazole on the detection of Helicobacter pylori in bleeding peptic ulcer patients. Scand. J. Gastroenterol. 2003 38 : 588 93.